Written questions by Dance.

What progress his department has made in implementing the Advisory Council on the Misuse of Drugs recommendation to reduce barriers to research into promising treatments for cluster headaches.

The Department of Health and Social Care is working with officials in the Home Office to support the changes agreed to in the letter from the Minister of State at the Department for Work and Pensions and the Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health from July 2025. The group has met with stakeholders from the clinical trials community who gave advice and assurance on the proposed changes to the legislation.The Department is committed to turbocharging clinical research and delivering better patient care, to make the United Kingdom a world-leading destination for clinical research. We are working to fast-track clinical trials, reducing barriers and unnecessary bureaucracy to drive global investment into life sciences, improve health outcomes, and accelerate the development of the medicines and therapies of the future, including treatments for cluster headaches. We expect these efforts to attract more commercial investment in clinical research and to yield a broad and diverse portfolio of clinical trials in the UK.The Department is committed to ensuring that all patients, including those with cluster headaches, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

How many people with young onset dementia have received a care plan review in the most recent period for which data is available in (a) Yeovil constituency and (b) England.

We do not hold data for the Yeovil constituency centrally. In England, 369,635, or 72.4%, of those with a recorded diagnosis of dementia on 28 February 2026 received a care plan or care plan review in the preceding 12 months. This information is found in the Primary Care Dementia Data, published at the following link:https://digital.nhs.uk/data-and-information/publications/statistical/primary-care-dementia-data

What steps he is taking to improve the accuracy and consistency of coding practices for young onset dementia across health systems.

To strengthen both local and national insight into dementia care, enable clearer benchmarking, and support the delivery of more timely, targeted, and person-centred support, NHS England continues to monitor the monthly dementia diagnosis rate and analyse trends at national, regional, and integrated care board level. The commitment to recover diagnosis rates to the national ambition, of 66.7%, remains in place, ensuring identification and appropriate support for people living with dementia.The national ambition to ensure that two-thirds of people estimated to have dementia receive a formal diagnosis includes ensuring provision of a validated diagnosis of dementia subtype.In addition, NHS England is actively looking to improve the clinical utility and relevance of dementia data reporting. This includes:enhancing primary care reporting through ongoing refinement of indicators and coding approaches. Notably, a new measure was introduced in April 2025 capturing the number of people with dementia who have experienced delirium in the past 12 months. This will support systems and providers to better understand variation in care provision, improve risk stratification, and strengthen care planning; andexploring improvements in the Mental Health Services Data Set to ensure activity within Memory Assessment Services is more fully reflected in available data. Work is underway with the NHS England analyst team to scope options for developing more meaningful coverage and consistency in memory service reporting.

What steps he is taking to co-ordinate the Modern Service Framework for Frailty and Dementia with the Modern Service Framework for Palliative and End of Life Care.

We will deliver the first ever Modern Service Framework (MSF) for Frailty and Dementia. This will be complemented by an MSF for Palliative Care and End of Life Care. Together these MSFs will drive rapid and significant improvements in quality of care and productivity. We are committed to publishing an interim product for the MSF for Frailty and Dementia in September this year to feed into National Health Service and local government planning cycles, and will aim to publish the full MSF by the end of this calendar year as recommended by Baroness Casey.The MSF for Palliative Care and End of Life Care, with a planned publication date of Autumn 2026, will drive improvements in the services that patients and their families receive at the end of life, including those living with dementia, and will enable integrated care boards to address challenges in access, quality, and sustainability through the delivery of high-quality, personalised care. We are committed to publishing an interim product for the Palliative Care and End of Life Care in Spring.We intend to engage with a range of partners over the coming months to enable us to build frameworks which are both ambitious and practical, to ensure we can improve system performance for people with dementia both now and in the future. The teams responsible for the MSFs are working together to ensure alignment and co-ordination.

What assessment he has made of the potential impact of the planned reductions in share of NHS spending going to mental health services for three consecutive years on rural communities in Yeovil constituency.

As set out in a Written Ministerial Statement published on 12 March, National Health Service mental health expenditure is forecast to reach £16.1 billion in 2026/27, representing a real‑terms increase of £140 million compared with 2025/26. The proportion of overall NHS spending allocated to mental health in 2026/27 is forecast to be 8.4%, just 0.28% lower than in 2025/26. This reflects significant additional investment across the wider NHS, including in technology and digital transformation, strengthening general practice, and establishing neighbourhood health centres. The headline share‑of‑spend metric also does not capture the full range of mental health investment. This includes £473 million of capital funding over the next four years to support the roll‑out of capital projects such as Community‑Based Mental Health Centres and Mental Health Emergency Departments. Further detail on integrated care board (ICB) allocations is available at the following link: https://www.england.nhs.uk/publication/allocation-of-resources-2026-27-to-2027-28/ In addition, the Government continues to require all ICBs to meet the Mental Health Investment Standard over the next three years, which sets a minimum rate of growth in local mental health spending. As a result, NHS Somerset will continue to increase investment in mental health services across Somerset. The 10-Year Health Plan set out an ambitious reform agenda to transform the NHS and make it fit for the future. In line with this, we will go further to ensure that NHS mental health services deliver the care that people deserve. We know that there is much more to do to improve outcomes, tackle unacceptable waiting times for care and fully meet the needs of the population in a tailored, personalised and timely way. NHS Somerset recognises the additional challenges associated with delivering services in rural areas. Through its transformed community mental health offer, Open Mental Health, a partnership between the Somerset NHS Foundation Trust and voluntary, community, faith and social enterprise partners, access to high‑quality mental health support has been expanded for people in rural communities, including through face‑to‑face provision, digital services, and telephone‑based support.

What assessment he has made of the role community pharmacy could play in providing a Meningitis B vaccine catch-up service to students and young people from Yeovil constituency at risk.

The Government is looking to expand the number of vaccines offered in community pharmacies across the country through local, targeted vaccination programmes. This has already started, with NHS England commissioning some community pharmacies in the Midlands, North West, London, and East of England to help deliver the year-round respiratory syncytial virus vaccination programmes to eligible pregnant women, to protect newborns, and adults aged 75 to 79 years old as well as the year-round pertussis vaccination programme to eligible pregnant women.NHS England also nationally commissioned community pharmacies to administer flu vaccines for two- and three-year-olds for the first time in autumn 2025. An evaluation will assess whether this use of community pharmacies improves vaccine uptake and helps tackle regional health inequalities, in line with the NHS Vaccination Strategy.The Joint Committee on Vaccination and Immunisation (JCVI) is an expert scientific advisory committee that advises the Government on eligibility for vaccination and immunisation programmes. The JCVI has been consulted on the immediate vaccine response to the outbreak and clinical effectiveness of potential future outbreak response vaccination strategies.On the 17 March, my Rt Hon. Friend, the Secretary of State for Health and Social Care, also announced to the House of Commons that he would ask the JCVI to review eligibility for meningococcal B (MenB) vaccination. The JCVI will conduct a full assessment of the cost-effectiveness of a routine adolescent MenB vaccination programme and provide a complete and formal response to my Rt Hon. Friend as soon as practicable.

What steps he is taking to raise public awareness of bowel cancer in Yeovil constituency.

NHS England has run national campaigns, most recently in early 2025, to increase knowledge of cancer symptoms, address barriers to acting on them, and to encourage people to see their general practitioner as soon as possible if they notice a change in their health. The campaigns cover bowel cancer and have focused on increasing awareness of a range of symptoms, as well as encouraging general body awareness, to help people spot symptoms across a wide range of cancers at an earlier point.The National Health Service in England encourages everyone aged 50 to 74 years old, including in the Yeovil constituency, to take part in bowel cancer screening. The UK Bowel Cancer Screening Programme is undergoing several updates to its standards aimed at improving coverage, accessibility, and early detection. This includes updated performance thresholds, and improved accessibility of bowel cancer screening faecal immunochemical test kits.NHS England and other National Health Service organisations, nationally and locally, publish information on the signs and symptoms of many different types of cancer, including bowel cancer. This information can be found at sources including the NHS website, which is available at the following link:https://www.nhs.uk/From 2026, Cancer Alliances will receive funding and work proactively with local communities and providers to improve early diagnosis rates. They will focus on increasing awareness of cancer symptoms, supporting primary care to spot signs of cancer early, and reducing the gap in screening uptake between the most and least deprived areas, with particular efforts to reach ethnic minority and underserved communities.

What steps he is taking to support NHS Somerset to increase participation in bowel cancer screening in Yeovil constituency.

Coverage of bowel cancer screening has been increasing in recent years. In 2019, 60.5% of people took the offer up. Now, it is 71.8%.To further increase coverage across England, including Yeovil, NHS England is doing the following:delivering new approaches to communicating with people about screening through the NHS App;incorporating the reasonable adjustment flag into screening to ensure that people get information in the way they want, and that adjustments are made to support people at appointments;has recently updated the bowel cancer screening leaflets and is updating the bowel cancer screening letters to improve accessibility; andhas made the bowel cancer screening faecal immunochemical test kit more accessible for people who are blind or partially sighted.

What assessment she has made of the potential impact of prescription charges on people with Cystic Fibrosis in Yeovil constituency.

The Government has not made an assessment of the potential impact of prescription charges on people with cystic fibrosis in the Yeovil constituency. Pursuant to the answer of 27 January, no assessment has been made of the potential merits of reviewing the list of medical conditions that entitle someone to apply for a medical exemption certificate.

Pursuant to the answer received on the 27 January 2026 on Cystic Fibrosis: Prescriptions [Question 107568], what assessment he has made of the potential merits of reviewing the list of medical conditions that entitle someone to apply for a medical exemption certificate which exempts the holder from paying the National Health Service prescription charge.

The Government has not made an assessment of the potential impact of prescription charges on people with cystic fibrosis in the Yeovil constituency. Pursuant to the answer of 27 January, no assessment has been made of the potential merits of reviewing the list of medical conditions that entitle someone to apply for a medical exemption certificate.

Whether the new end of treatment summaries set out in the National Cancer Plan will include guaranteed information on the signs and symptoms of secondary breast cancer.

The National Cancer Plan, published on 4 February, sets out several commitments and ambitions, to be delivered within the next 10 years, including end of treatment summaries.Every cancer patient will receive a summary that will inform the ongoing care they receive from neighbourhood health services. As the summary will be co-produced between the patient can their clinical team, it will reflect the patient’s own understanding of their condition and their individual needs, including personalised information and advice on secondary cancer symptoms where relevant. End of treatment summaries will link back to the patient’s personal cancer care plan, and offer a rapid route back to hospital if they need it.

Pursuant to the answer of 06.01.2026 to question 103582 on Tourette’s Syndrome: Health Services, what steps he is taking to support Tourette’s Action to disseminate their e-learning module for GPs in (a) Yeovil constituency, (b) Somerset and (c) England.

The commissioning of services for Tourette’s syndrome is the responsibility of local integrated care boards (ICBs), which have a legal duty to plan comprehensive health services for their populations, including for conditions like Tourette’s. While Somerset NHS Foundation Trust has not been directly approached to promote these e-learning modules, it would welcome reviewing the content and, if appropriate, would be happy to share more widely.Cutting waiting lists is a key priority for the Government, including for neurology services. Between September 2024 and September 2025, the number of incomplete neurology pathways was reduced by 15,500, from 234,720 to 219,221, and the average waiting time for neurology services fell from 16.2 to 15.2 weeks. Over the same period, the proportion of patients seen within 18 weeks increased to around 57%, up from around 54% the previous year. We remain committed to returning to the NHS constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029. As part of the Elective Reform Plan, we are investing in additional capacity and reforming outpatient services to help bring waiting times down, recognising that neurology is a particularly challenged specialty.NHS England’s Neuroscience Transformation Programme is supporting ICBs to improve pathways, reduce unwarranted variation and provide care closer to home for neurology patients, including for patients with Tourette’s.The Mental Health Act 2025 is a critical foundation to ensure that people with the most severe mental health conditions get better, more personalised care, and have greater choice and control over their treatment. NHS England’s mental health, learning disability and autism inpatient quality transformation programme will support cultural change and a new model of care for the future across all NHS-funded mental health inpatient settings. Local health systems have now published their three-year plans for localising and realigning inpatient care in line with this vision.

Pursuant to the answer of 06.01.2026 to question 103582 on Tourette’s Syndrome: Health Services, what assessment he has made of the quality of management of Tourette’s in mental health hospitals.

The commissioning of services for Tourette’s syndrome is the responsibility of local integrated care boards (ICBs), which have a legal duty to plan comprehensive health services for their populations, including for conditions like Tourette’s. While Somerset NHS Foundation Trust has not been directly approached to promote these e-learning modules, it would welcome reviewing the content and, if appropriate, would be happy to share more widely.Cutting waiting lists is a key priority for the Government, including for neurology services. Between September 2024 and September 2025, the number of incomplete neurology pathways was reduced by 15,500, from 234,720 to 219,221, and the average waiting time for neurology services fell from 16.2 to 15.2 weeks. Over the same period, the proportion of patients seen within 18 weeks increased to around 57%, up from around 54% the previous year. We remain committed to returning to the NHS constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029. As part of the Elective Reform Plan, we are investing in additional capacity and reforming outpatient services to help bring waiting times down, recognising that neurology is a particularly challenged specialty.NHS England’s Neuroscience Transformation Programme is supporting ICBs to improve pathways, reduce unwarranted variation and provide care closer to home for neurology patients, including for patients with Tourette’s.The Mental Health Act 2025 is a critical foundation to ensure that people with the most severe mental health conditions get better, more personalised care, and have greater choice and control over their treatment. NHS England’s mental health, learning disability and autism inpatient quality transformation programme will support cultural change and a new model of care for the future across all NHS-funded mental health inpatient settings. Local health systems have now published their three-year plans for localising and realigning inpatient care in line with this vision.

Pursuant to the answer of 06.01.2026 to question 103582 on Tourette’s Syndrome: Health Services, what steps he is taking to continue to minimise waiting times for Tourette’s diagnosis.

The commissioning of services for Tourette’s syndrome is the responsibility of local integrated care boards (ICBs), which have a legal duty to plan comprehensive health services for their populations, including for conditions like Tourette’s. While Somerset NHS Foundation Trust has not been directly approached to promote these e-learning modules, it would welcome reviewing the content and, if appropriate, would be happy to share more widely.Cutting waiting lists is a key priority for the Government, including for neurology services. Between September 2024 and September 2025, the number of incomplete neurology pathways was reduced by 15,500, from 234,720 to 219,221, and the average waiting time for neurology services fell from 16.2 to 15.2 weeks. Over the same period, the proportion of patients seen within 18 weeks increased to around 57%, up from around 54% the previous year. We remain committed to returning to the NHS constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029. As part of the Elective Reform Plan, we are investing in additional capacity and reforming outpatient services to help bring waiting times down, recognising that neurology is a particularly challenged specialty.NHS England’s Neuroscience Transformation Programme is supporting ICBs to improve pathways, reduce unwarranted variation and provide care closer to home for neurology patients, including for patients with Tourette’s.The Mental Health Act 2025 is a critical foundation to ensure that people with the most severe mental health conditions get better, more personalised care, and have greater choice and control over their treatment. NHS England’s mental health, learning disability and autism inpatient quality transformation programme will support cultural change and a new model of care for the future across all NHS-funded mental health inpatient settings. Local health systems have now published their three-year plans for localising and realigning inpatient care in line with this vision.

What assessment he has made of the potential merits of updating National Institute for Health and Care Excellence guidelines on anxiety.

The Government has made no such assessment. National Institute for Health and Care Excellence (NICE) guidelines are developed independently by experts based on a thorough assessment of the available evidence and through extensive engagement with a wide range of stakeholders. They represent best practice and healthcare professionals are expected to take them fully into account in the care and treatment of their patients. NICE keeps its guidance under active surveillance and decisions on whether published guidelines should be updated in light of new evidence are taken by the NICE prioritisation board, chaired by the NICE Chief Medical Officer, in line with its published prioritisation framework. There are currently no plans to update the guideline on generalised anxiety or panic disorder.

What steps he is taking to support NHS services in Somerset to improve coordination between community mental health teams and specialist diabetes services in (a) Yeovil constituency and (b) Somerset.

Improving the integration between community mental health services and other physical health services and meeting the holistic needs of people with severe mental health problems is a priority, as set out in the Community Mental Health Framework.The National Health Service in Somerset, including Yeovil, has a personalised care programme which seeks to recognise individual needs, knowledge, and priorities. Where someone has needs that encompass mental health and diabetes services, Somerset’s personalised care programme will meet those needs by bringing together tailored input from specialist teams. This work will be developed as part of neighbourhood commissioning in the coming years, enabling services to work together to meet complex needs.

What assessment he has made of the potential impact of the rising cost of Actimorph on its provision in Yeovil constituency.

The Drug Tariff, a monthly publication, sets out reimbursement prices to be paid to pharmacy contractors for the medicines that they dispense. Whilst we do not look at specific areas of the United Kingdom or specific medicines, we do have arrangements in place to mitigate against rising medication costs for pharmacies, that ensure they are paid enough overall above what it costs them to purchase medicines.Where prices increase significantly and rapidly, concessionary prices can be granted by the Department to ensure that pharmacy contractors are paid fairly, and can access medicines for their patients, even when market prices increase.Concessionary prices are set using 'real time' market data provided to the Department under the Health Service Products (Provision and Disclosure of Information) Regulations 2018 on prices and stock levels intended for retail pharmacy businesses in England. This ensures that prices set are reflective of the market and aims to reimburse pharmacy contractors fairly.For branded medicine such as Actimorph the Department sets maximum list prices which are controlled through the Voluntary scheme for branded medicines Pricing, Access and Growth and the statutory scheme.

What assessment he has made of the potential impact of rising medication costs on (a) pharmacies in Yeovil constituency and (b) their ability to provide prescriptions.

The Drug Tariff, a monthly publication, sets out reimbursement prices to be paid to pharmacy contractors for the medicines that they dispense. Whilst we do not look at specific areas of the United Kingdom or specific medicines, we do have arrangements in place to mitigate against rising medication costs for pharmacies, that ensure they are paid enough overall above what it costs them to purchase medicines.Where prices increase significantly and rapidly, concessionary prices can be granted by the Department to ensure that pharmacy contractors are paid fairly, and can access medicines for their patients, even when market prices increase.Concessionary prices are set using 'real time' market data provided to the Department under the Health Service Products (Provision and Disclosure of Information) Regulations 2018 on prices and stock levels intended for retail pharmacy businesses in England. This ensures that prices set are reflective of the market and aims to reimburse pharmacy contractors fairly.For branded medicine such as Actimorph the Department sets maximum list prices which are controlled through the Voluntary scheme for branded medicines Pricing, Access and Growth and the statutory scheme.

What steps he is taking to improve public representation in NHS Foundation Trusts.

The removal of the councils of governors from National Health Service foundation trusts (FTs) forms part of the wider aim of the 10-Year Health Plan to ensure that hospitals put patient experiences and outcomes at the heart of their decision-making. The regulatory functions supporting oversight of the governance of FTs are underpinned by the NHS provider licence which will continue.While governors elected by the public and other stakeholders have provided helpful advice and oversight for some FTs, we now need to move to a more dynamic model, drawing on patient, staff, and stakeholder insight. For example, approaches to engagement that better reflect local demographics and geography rather than a ‘one size fits all’ governor model, as well as supporting an increasing focus on the outcomes of the engagement, including the evidence that local people are involved in key decisions about how care is provided and their voices are listened to.

What assessment he has made of the potential impact of the removal of Council of Governors from foundation trusts on the governance of those trusts.

The removal of the councils of governors from National Health Service foundation trusts (FTs) forms part of the wider aim of the 10-Year Health Plan to ensure that hospitals put patient experiences and outcomes at the heart of their decision-making. The regulatory functions supporting oversight of the governance of FTs are underpinned by the NHS provider licence which will continue.While governors elected by the public and other stakeholders have provided helpful advice and oversight for some FTs, we now need to move to a more dynamic model, drawing on patient, staff, and stakeholder insight. For example, approaches to engagement that better reflect local demographics and geography rather than a ‘one size fits all’ governor model, as well as supporting an increasing focus on the outcomes of the engagement, including the evidence that local people are involved in key decisions about how care is provided and their voices are listened to.